Pricing Log in Create free account

Nektar Therapeutics (NKTR) vs Silence Therapeutics PLC Sponsored ADR (SLN)

Nektar Therapeutics and Silence Therapeutics PLC Sponsored ADR are both Biotechnology companies. Nektar Therapeutics and Silence Therapeutics PLC Sponsored ADR are of similar size ($1.2B and $1.2B). Nektar Therapeutics grew revenue faster over the last twelve months: −27.2% against −97.0%. Silence Therapeutics PLC Sponsored ADR has the higher net margin (0.00% vs −287.8%) and the higher return on invested capital (0.00% vs −40.2%). Across the 17 metrics below, Nektar Therapeutics leads on 10 and Silence Therapeutics PLC Sponsored ADR on 7.

Valuation

Metric NKTR SLN Biotechnology median
P/E n/m n/m 10.60
P/S 22.56 1,110.83 9.40
P/B 1.36 24.23 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 19.22 1,025.03 9.02
Earnings yield (17.99%) (6.49%) (32.88%)
Free cash flow yield (19.01%) (4.54%) (23.13%)

Profitability

Metric NKTR SLN Biotechnology median
Gross margin 100.00% 79.50% 68.51%
Operating margin (257.80%) 0.00% 0.00%
Net margin (287.84%) 0.00% 0.00%
Free cash flow margin (428.72%) 0.00% 0.00%
Return on equity (35.75%) (90.41%) (51.96%)
Return on assets (24.12%) (44.14%) (46.06%)
Return on invested capital (40.20%) 0.00% 0.00%

Growth

Metric NKTR SLN Biotechnology median
Revenue growth (TTM) (27.15%) (96.97%) 6.76%
EPS growth (last fiscal year) (11.89%) (90.91%) 29.88%
Revenue growth, 5-year CAGR (18.43%) (39.74%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NKTR SLN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.42 7.42 4.97
Net debt to EBITDA 1.77 0.94 1.01

Dividend

Metric NKTR SLN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NKTR SLN Biotechnology median
Market cap 1.23b 1.23b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack